Literature DB >> 1906024

Reduced glycogen synthase activity in skeletal muscle from obese patients with and without type 2 (non-insulin-dependent) diabetes mellitus.

P Damsbo1, A Vaag, O Hother-Nielsen, H Beck-Nielsen.   

Abstract

In order to evaluate the importance of a defect in insulin mediated non-oxidative glucose metabolism and glycogen synthase activity in skeletal muscles in obese subjects with and without Type 2 (non-insulin-dependent) diabetes mellitus we studied: 10 lean and 10 obese control subjects and 12 obese diabetic patients using the euglycaemic hyperinsulinaemic clamp technique (basal, 20 mU.(m2)-1.min-1, 80 mU.(m2)-1.min-1) in combination with indirect calorimetry. Muscle biopsies were taken from m. vastus lateralis at each insulin level. We found that non-oxidative glucose metabolism could be stimulated by insulin in all three groups (p less than 0.01). The values obtained at the highest insulin levels (around 140 microU/ml) were lower in both obese groups compared to the lean control subjects (118 +/- 21, 185 +/- 31, 249 +/- 14 mg.(m2)-1.min-1 (p less than 0.01]. Insulin stimulation of the glycogen synthase activity at a glucose-6-phosphate concentration of 0.1 mmol/l was absent in both obese groups, while activities increased significantly in the lean control subjects (19.6 +/- 4.2% to 45.6 +/- 6.8%, p less than 0.01). Glycogen synthase activities at the highest insulin concentrations only differed significantly between lean control subjects and obese diabetic patients (45 +/- 7% and 31 +/- 5%, p less than 0.05). We conclude that insulin resistance in peripheral tissues in obese subjects with and without Type 2 diabetes may be partly explained by a reduced insulin mediated non-oxidative glucose metabolism and that this abnormality might be due to an absent insulin stimulation of glycogen synthase in skeletal muscles. This enzyme defect is correlated to obesity itself.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1906024     DOI: 10.1007/bf00405082

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  28 in total

1.  Defective insulin receptor tyrosine kinase in human skeletal muscle in obesity and type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  P Arner; T Pollare; H Lithell; J N Livingston
Journal:  Diabetologia       Date:  1987-06       Impact factor: 10.122

2.  Decreased activation of skeletal muscle glycogen synthase by mixed-meal ingestion in NIDDM.

Authors:  K S Wright; H Beck-Nielsen; O G Kolterman; L J Mandarino
Journal:  Diabetes       Date:  1988-04       Impact factor: 9.461

3.  Glucose disposal in obese non-diabetic and diabetic type II patients. A study by indirect calorimetry and euglycemic insulin clamp.

Authors:  A Golay; R A Defronzo; D Thorin; E Jequier; J P Felber
Journal:  Diabete Metab       Date:  1988 Jul-Aug

4.  Insulin receptor kinase in human skeletal muscle from obese subjects with and without noninsulin dependent diabetes.

Authors:  J F Caro; M K Sinha; S M Raju; O Ittoop; W J Pories; E G Flickinger; D Meelheim; G L Dohm
Journal:  J Clin Invest       Date:  1987-05       Impact factor: 14.808

5.  Enhanced hepatic insulin sensitivity, but peripheral insulin resistance in patients with type 1 (insulin-dependent) diabetes.

Authors:  O Hother-Nielsen; O Schmitz; J Bak; H Beck-Nielsen
Journal:  Diabetologia       Date:  1987-11       Impact factor: 10.122

6.  Insulin resistance and hypertriglyceridemia in nondiabetic relatives of patients with noninsulin-dependent diabetes mellitus.

Authors:  A Laws; M L Stefanick; G M Reaven
Journal:  J Clin Endocrinol Metab       Date:  1989-08       Impact factor: 5.958

7.  Reversibility of defective adipocyte insulin receptor kinase activity in non-insulin-dependent diabetes mellitus. Effect of weight loss.

Authors:  G R Freidenberg; D Reichart; J M Olefsky; R R Henry
Journal:  J Clin Invest       Date:  1988-10       Impact factor: 14.808

8.  Skeletal muscle glycolysis, oxidation, and storage of an oral glucose load.

Authors:  D Kelley; A Mitrakou; H Marsh; F Schwenk; J Benn; G Sonnenberg; M Arcangeli; T Aoki; J Sorensen; M Berger
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

9.  Distribution of in vivo insulin action in Pima Indians as mixture of three normal distributions.

Authors:  C Bogardus; S Lillioja; B L Nyomba; F Zurlo; B Swinburn; A Esposito-Del Puente; W C Knowler; E Ravussin; D M Mott; P H Bennett
Journal:  Diabetes       Date:  1989-11       Impact factor: 9.461

10.  Effects of insulin infusion on human skeletal muscle pyruvate dehydrogenase, phosphofructokinase, and glycogen synthase. Evidence for their role in oxidative and nonoxidative glucose metabolism.

Authors:  L J Mandarino; K S Wright; L S Verity; J Nichols; J M Bell; O G Kolterman; H Beck-Nielsen
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

View more
  46 in total

Review 1.  Cellular mechanisms of insulin resistance.

Authors:  G I Shulman
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

Review 2.  Alterations of glucose metabolism in type 2 diabetes mellitus. An overview.

Authors:  Riccardo C Bonadonna
Journal:  Rev Endocr Metab Disord       Date:  2004-05       Impact factor: 6.514

3.  Unchanged gene expression of glycogen synthase in muscle from patients with NIDDM following sulphonylurea-induced improvement of glycaemic control.

Authors:  H Vestergaard; S Lund; C Bjørbaek; O Pedersen
Journal:  Diabetologia       Date:  1995-10       Impact factor: 10.122

4.  Dysregulation of muscle glycogen synthase in recovery from exercise in type 2 diabetes.

Authors:  Andreas J T Pedersen; Janne R Hingst; Martin Friedrichsen; Jonas M Kristensen; Kurt Højlund; Jørgen F P Wojtaszewski
Journal:  Diabetologia       Date:  2015-04-14       Impact factor: 10.122

Review 5.  Insulin resistance and improvements in signal transduction.

Authors:  Nicolas Musi; Laurie J Goodyear
Journal:  Endocrine       Date:  2006-02       Impact factor: 3.633

6.  Insulin resistance in striated muscle-specific integrin receptor beta1-deficient mice.

Authors:  Haihong Zong; Claire C Bastie; Jun Xu; Reinhard Fassler; Kevin P Campbell; Irwin J Kurland; Jeffrey E Pessin
Journal:  J Biol Chem       Date:  2008-12-08       Impact factor: 5.157

7.  Dual regulation of muscle glycogen synthase during exercise by activation and compartmentalization.

Authors:  Clara Prats; Jørn W Helge; Pernille Nordby; Klaus Qvortrup; Thorkil Ploug; Flemming Dela; Jørgen F P Wojtaszewski
Journal:  J Biol Chem       Date:  2009-04-01       Impact factor: 5.157

8.  Multiple defects of both hepatic and peripheral intracellular glucose processing contribute to the hyperglycaemia of NIDDM.

Authors:  A Vaag; F Alford; F L Henriksen; M Christopher; H Beck-Nielsen
Journal:  Diabetologia       Date:  1995-03       Impact factor: 10.122

9.  Hyperglycaemia compensates for the defects in insulin-mediated glucose metabolism and in the activation of glycogen synthase in the skeletal muscle of patients with type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  A Vaag; P Damsbo; O Hother-Nielsen; H Beck-Nielsen
Journal:  Diabetologia       Date:  1992-01       Impact factor: 10.122

10.  Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus.

Authors:  A Vaag; J E Henriksen; H Beck-Nielsen
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.